MedImmune Ltd
10% Owner
MedImmune Ltd10% Owner
MedImmune Ltd insider trades: Aevi Genomic Medicine (GNMX) SEC Form 4 filings
10% Owner, Aevi Genomic Medicine 1 Form 4 filing
1
Form 4 filings
last Feb 7, 2020
1
Company
Companies
Where MedImmune Ltd reports to the SEC
About MedImmune Ltd's insider trades
MedImmune Ltd is a 10% owner of Aevi Genomic Medicine (GNMX). It has not reported an open-market purchase or sale.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GNMX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.